Nanoviricides (NNVC) Shares Outstanding (2010 - 2026)

Nanoviricides has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $21.6 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 34.69% year-over-year to $21.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.6 million (up 34.69% YoY) and the FY2025 annual result came in at $16.6 million, up 26.34% from the prior year.
• Shares Outstanding (Entity) was little changed at $21.6 million in Q1 2026 per NNVC's latest filing, from $21.6 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $21.6 million in Q1 2026 and troughed at $1.7 million in Q1 2023.
• A 5-year average of $12.5 million and a median of $11.8 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) plunged 85.25% in 2023, then soared 593.1% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $1.7 million in 2022, then soared by 579.1% to $11.8 million in 2023, then jumped by 32.8% to $15.6 million in 2024, then surged by 38.06% to $21.6 million in 2025, then climbed by 0.24% to $21.6 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $21.6 million, $21.6 million, and $17.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.